More info:

• Luvox: Effective OCD and Depression Management - Evidence-Based Review

  Fluvoxamine, marketed under the brand name Luvox among others, is a selective serotonin reuptake inhibitor (SSRI) antidepressant primarily used to treat major depressive disorder and obsessive-compulsive disorder. It’s one of those workhorse medications that’s been in clinical practice for decades - not the flashiest SSRI, but incredibly reliable for specific patient populations. What’s fascinating is how its unique receptor profile sets it apart from other SSRIs, particularly its sigma-1 receptor agonism, which has sparked renewed interest in recent years for potential applications beyond its traditional indications.

• anafranil

  Anafranil, known generically as clomipramine, is a tricyclic antidepressant (TCA) primarily used for obsessive-compulsive disorder (OCD). It’s one of those older agents that, frankly, we don’t reach for as a first-line for depression anymore due to side effects, but for OCD? It remains a cornerstone, arguably the most effective pharmacologic agent we have. Its mechanism is distinct, with potent serotonin reuptake inhibition that predates the SSRIs. I remember my first year in psychopharmacology, the attending told me, “If you want to understand OCD treatment, you start and end with clomipramine.

• clozaril

  Clozaril represents one of the most significant advances in treatment-resistant schizophrenia management, yet remains widely misunderstood even among experienced clinicians. When I first encountered this medication during my residency at Massachusetts General, the hematological monitoring requirements seemed so burdensome we almost avoided using it entirely - a decision that would have profoundly impacted dozens of patients I’ve since treated successfully. Clozaril: Breakthrough Treatment for Treatment-Resistant Schizophrenia - Evidence-Based Review 1. Introduction: What is Clozaril?

• cymbalta

  Cymbalta, known generically as duloxetine, is a serotonin-norepinephrine reuptake inhibitor (SNRI) primarily prescribed for major depressive disorder, generalized anxiety disorder, and certain chronic pain conditions like diabetic peripheral neuropathy and fibromyalgia. It’s not a dietary supplement but a prescription medication with a well-defined mechanism and substantial clinical backing. The development of Cymbalta was actually quite contentious internally—our team debated for months whether to prioritize its norepinephrine reuptake inhibition equally with serotonin, given the older SSRIs were dominating the market at the time.

• Esbriet: Slowing Disease Progression in Idiopathic Pulmonary Fibrosis - Evidence-Based Review

  Pirfenidone, marketed under the brand name Esbriet, represents a significant advancement in the management of idiopathic pulmonary fibrosis (IPF). This orally administered small molecule belongs to the antifibrotic class of medications and has demonstrated efficacy in slowing disease progression in this relentless condition. When I first encountered Esbriet in clinical trials over a decade ago, I was skeptical—we’d seen so many potential IPF treatments fail. But the mechanism targeting multiple pathways of fibrosis showed genuine promise that eventually translated to meaningful clinical benefits.

• Eulexin: Advanced Prostate Cancer Management - Evidence-Based Review

  Flutamide, marketed under the brand name Eulexin among others, is a non-steroidal anti-androgen medication primarily used in the management of advanced prostate cancer. It works by competitively blocking the effects of androgens like testosterone on their receptors, thereby inhibiting the growth of prostate cancer cells that are hormone-sensitive. Eulexin is typically administered in combination with a luteinizing hormone-releasing hormone (LHRH) agonist as part of maximal androgen blockade therapy. This approach aims to achieve more complete suppression of androgen activity than either agent alone.

• melatonin

  Melatonin is an endogenous neurohormone primarily synthesized and secreted by the pineal gland in a circadian rhythm, with peak levels occurring during the night in darkness. It’s classified as a dietary supplement in most markets and available in various formulations including immediate-release tablets, sustained-release capsules, and liquid forms. What’s fascinating is how this simple indoleamine has evolved from being considered just a “sleep hormone” to having pleiotropic effects throughout the body.

• Olanzapine: Effective Symptom Control for Serious Mental Illness - Evidence-Based Review

  Olanzapine is an atypical antipsychotic medication primarily used in the management of schizophrenia, bipolar disorder, and as an adjunct in treatment-resistant depression. It functions as a multi-receptor targeting agent with high affinity for serotonin 5-HT2A/2C, dopamine D1-4, muscarinic M1-5, histamine H1, and adrenergic α1 receptors. This broad receptor profile explains both its therapeutic efficacy and its particular side effect spectrum, which we’ll explore in depth. Available in oral tablets, orally disintegrating tablets (Zydis), and short-acting intramuscular formulations, olanzapine represents a cornerstone in acute and maintenance treatment of several serious psychiatric conditions.

• Pirfenex: Targeted Anti-Fibrotic Action for Idiopathic Pulmonary Fibrosis - Evidence-Based Review

  Pirfenex represents one of those rare cases where an old molecule found new life through clever formulation. We’re talking about pirfenidone, which has been floating around pharmacology textbooks since the 1970s, but only recently became clinically relevant thanks to better delivery systems and a deeper understanding of fibrotic pathways. What started as a compound with modest anti-inflammatory properties has evolved into a targeted anti-fibrotic agent that’s changing how we manage progressive scarring conditions.